These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 8127143)

  • 81. In vitro studies of haematopoietic colony-forming capacity of human fetal liver cells at exposure to cytotoxic and immunomodulatory drugs.
    Lindton B; Markling L; Ringdén O; Westgren M
    Fetal Diagn Ther; 2002; 17(2):104-9. PubMed ID: 11844915
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Comparison of idarubicin and daunorubicin and their main metabolites regarding intracellular uptake and effect on sensitive and multidrug-resistant HL60 cells.
    Tidefelt U; Prenkert M; Paul C
    Cancer Chemother Pharmacol; 1996; 38(5):476-80. PubMed ID: 8765443
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Idarubicin and idarubicinol effects on breast cancer multicellular spheroids.
    Orlandi P; Barbara C; Bocci G; Fioravanti A; Di Paolo A; Del Tacca M; Danesi R
    J Chemother; 2005 Dec; 17(6):663-7. PubMed ID: 16433198
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Deoxycytidine stimulates the in vitro growth of normal CFU-GM and reverses the negative regulatory effects of acidic isoferritin and prostaglandin E1.
    Bhalla K; Cole J; MacLaughlin W; Baker M; Arlin Z; Graham G; Grant S
    Blood; 1986 Nov; 68(5):1136-41. PubMed ID: 3464321
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Human placenta-conditioned medium for stimulation of human granulopoietic precursor cell (CFU-C) colony growth in vitro.
    Lohrmann HP; Hansi W; Heimpel H
    Blut; 1978 Feb; 36(2):81-8. PubMed ID: 305795
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Toxicity of novel anthracycline derivatives towards normal myeloid bone marrow progenitor cells (CFU-GM) is not increased by verapamil.
    Busch FW; Schmittele U; Ehninger G
    Blut; 1990 Apr; 60(4):219-22. PubMed ID: 2337680
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Evaluation of dimethylaminosulfonates of alkane diols as a novel group of anticancer agents.
    Sanyal U; Nanda R; Samanta S; Pain A; Dutta S; Verma AS; Rider BJ; Agrawal KC
    Cancer Lett; 2000 Jul; 155(1):89-97. PubMed ID: 10814884
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Human bone marrow fibroblast proliferation and GM-CFC colony formation in patients with acute leukemia.
    Lieberman D; Meytes D; Shacked N; Ramot B
    Acta Haematol; 1984; 72(5):309-14. PubMed ID: 6441411
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Lindane haematotoxicity confirmed by in vitro tests on human and rat progenitors.
    Parent-Massin D; Thouvenot D; Rio B; Riche C
    Hum Exp Toxicol; 1994 Feb; 13(2):103-6. PubMed ID: 7512355
    [TBL] [Abstract][Full Text] [Related]  

  • 90. A methylcellulose microculture assay for the in vitro assessment of drug toxicity on granulocyte/macrophage progenitors (CFU-GM).
    Pessina A; Croera C; Bayo M; Malerba I; Passardi L; Cavicchini L; Neri MG; Gribaldo L
    Altern Lab Anim; 2004 Mar; 32(1):17-23. PubMed ID: 15603550
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Thiorphan, an inhibitor of neutral endopeptidase/enkephalinase (CD10/CALLA) enhances cell proliferation in bone marrow cultures of patients with acute leukemia in remission.
    Stanović S; Boranić M; Petrovecki M; Batinić D; Skodlar J; Nemet D; Labar B
    Haematologia (Budap); 2000; 30(1):1-10. PubMed ID: 10841318
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Cytotoxicity and DNA damage caused by 4-demethoxydaunorubicin and its metabolite 4-demethoxy-13-hydroxydaunorubicin in human acute myeloid leukemia cells.
    Limonta M; Biondi A; Giudici G; Specchia G; Catapano C; Masera G; Barbui T; D'Incalci M
    Cancer Chemother Pharmacol; 1990; 26(5):340-2. PubMed ID: 2208574
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Role of SR-4987 stromal cells in the modulation of doxorubicin toxicity to in vitro granulocyte-macrophage progenitors (CFU-GM).
    Pessina A; Piccirillo M; Mineo E; Catalani P; Gribaldo L; Marafante E; Neri MG; Raimondi A
    Life Sci; 1999; 65(5):513-23. PubMed ID: 10462078
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Doxorubicin and the alkylating anthracycline 3'-deamino-3'-(3-cyano-4-morpholinyl) doxorubicin: comparative in vitro potency against leukemia and bone marrow cells.
    Beckman RA; McFall PJ; Sikic BI; Smith SD
    J Natl Cancer Inst; 1988 May; 80(5):361-5. PubMed ID: 3357201
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Amodiaquine-induced agranulocytosis: report of a case with in vitro studies of granulocyte-macrophage progenitor cells.
    Aymard JP; Rouveix B; Ferry R; Janot C; May T; Legras B; Streiff F
    Acta Haematol; 1989; 82(1):40-2. PubMed ID: 2505473
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Sensitivity of CFU-GM from normal human bone marrow and leukaemic clonogenic cells (CFU-L) from blood of patients with myelogenous leukaemia to 3'-deoxy-3'-fluorothymidine in comparison to 3'-azido-3'-deoxythymidine.
    Blau IW; Elstner E; Waechter M; Ihle R; von Janta-Lipinski M; Langen P
    Blut; 1989 Nov; 59(5):455-7. PubMed ID: 2819251
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Comparative effects of racemic verapamil vs R-verapamil on normal and leukemic progenitors.
    Visani G; Fogli M; Tosi P; Ottaviani E; Gamberi B; Cenacchi A; Manfroi S; Tura S
    Ann Hematol; 1993 Jun; 66(6):273-6. PubMed ID: 8318558
    [TBL] [Abstract][Full Text] [Related]  

  • 98. In-vitro effect of retinoic acid on normal and chronic myeloid leukemia granulopoiesis.
    Aglietta M; Piacibello W; Stacchini A; Sanavio F; Gavosto F
    Leuk Res; 1985; 9(7):879-83. PubMed ID: 3860698
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Comparison of the toxicity of fluconazole and other azole antifungal drugs to murine and human granulocyte-macrophage progenitor cells in vitro.
    Benko I; Hernádi F; Megyeri A; Kiss A; Somogyi G; Tegyey Z; Kraicsovits F; Kovács P
    J Antimicrob Chemother; 1999 May; 43(5):675-81. PubMed ID: 10382889
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Differential sensitivity to (dl)-5-methyltetrahydrofolate of normal CFU-GM and HL-60 cells.
    Gattei V; Bernabei PA; Ferrini PR
    Leuk Res; 1989; 13(7):595-8. PubMed ID: 2761291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.